Table 1.
Respondent demographic distributions across treatment conditions.
| Demographic variable | Estimation sample | Treatment condition [M (SD)] | |||
|---|---|---|---|---|---|
| “No” First = 0 | “No” First = 1 | Unsure = 0 | Unsure = 1 | ||
| Respondent age | COVID-19 vaccine | 28.42 (10.29) | 28.45 (10.16) | 28.77 (10.35) | 28.28 (10.16) |
| COVID-19 booster | 30.69 (10.58) | 27.88 (9.56) | 28.89 (9.81) | 29.56 (10.48) | |
| Influenza vaccine | 30.71 (10.55) | 27.88 (9.38) | 27.18 (8.59) | 30.29 (10.58) | |
| Female (%) | COVID-19 vaccine | 77.77 (41.59) | 79.33 (40.50) | 79.25 (40.57) | 78.23 (41.27) |
| COVID-19 booster | 69.23 (46.60) | 70.69 (45.91) | 71.05 (45.96) | 69.44 (46.39) | |
| Influenza vaccine | 69.23 (46.60) | 70.69 (45.91) | 71.05 (45.96) | 69.44 (46.39) | |
| White (%) | COVID-19 vaccine | 83.68 (36.96) | 84.78 (35.93) | 86.25 (34.45) | 83.29 (37.31) |
| COVID-19 booster | 80.77 (39.80) | 82.76 (38.10) | 81.58 (39.29) | 81.94 (38.73) | |
| Influenza vaccine | 80.76 (39.79) | 82.76 (38.10) | 81.58 (39.29) | 81.94 (38.73) | |